Home > Healthcare > Electronic Trial Master File (eTMF) Market > Table of Contents

Electronic Trial Master File (eTMF) Market Size – By Component (Software, Service), Delivery Mode (Licensed Enterprise, Cloud-based, Web-hosted), Clinical Trial Phase (I, II, III, IV), End-use (CRO, Pharma, Biotech, Med Device Companies) & Forecast, 2024 – 2032

  • Report ID: GMI8312
  • Published Date: Feb 2024
  • Report Format: PDF

Report Content

Chapter 1   Methodology & Scope

1.1    Market scope & definitions

1.2    Base estimates & calculations

1.3    Data collection

1.4    Forecast parameters

1.5    Data validation

1.6    Data sources

1.6.1    Primary

1.6.2    Secondary

1.6.2.1   Paid sources

1.6.2.2   Public sources

Chapter 2   Executive Summary

2.1    Industry 3600 synopsis

Chapter 3   Industry Insights

3.1    Industry ecosystem analysis

3.2    Industry impact forces

3.2.1    Growth drivers

3.2.1.1   Rising adoption of ETMF systems

3.2.1.2   Increasing externalization of clinical trial studies by large pharmaceutical and biopharmaceutical companies

3.2.1.3   Rise of mobile and remote access solutions

3.2.1.4   Technological advancements in electronic trial master file systems

3.2.2    Industry pitfalls & challenges

3.2.2.1   Dearth of skilled research professionals

3.3    Growth potential analysis

3.4    Regulatory landscape

3.5    Porter’s analysis

3.5.1    Supplier power

3.5.2    Buyer power

3.5.3    Threat of new entrants

3.5.4    Threat of substitutes

3.5.5    Industry rivalry

3.6    PESTEL analysis

Chapter 4   Competitive Landscape, 2023

4.1    Introduction

4.2    Company matrix analysis

4.3    Competitive analysis of major market players

4.4    Competitive positioning matrix

4.5    Strategic dashboard

Chapter 5   Market Estimates and Forecast, By Component, 2018 – 2032 ($ Million)

5.1    Key trends

5.2    Software

5.3    Services

Chapter 6   Market Estimates and Forecast, By Delivery Mode, 2018 – 2032 ($ Million)

6.1    Key trends

6.2    Licensed enterprise (on-premise) solutions

6.3    Cloud-based (SAAS) solutions

6.4    Web-hosted (On-demand) solutions

Chapter 7   Market Estimates and Forecast, By Clinical Trial Phase, 2018 – 2032 ($ Million)

7.1    Key trends

7.2    Phase I

7.3    Phase II

7.4    Phase III

7.5    Phase IV

Chapter 8   Market Estimates and Forecast, By End-Use, 2018 – 2032 ($ Million)

8.1    Key trends

8.2    Contract research organizations (CROs)

8.3    Medical device companies

8.4    Pharmaceutical and biotechnology companies

8.5    Hospitals and clinics

8.6    Other end-users

Chapter 9   Market Estimates and Forecast, By Region, 2018 – 2032 ($ Million)

9.1    Key trends, by region

9.2    North America

9.2.1    U.S.

9.2.2    Canada

9.3    Europe

9.3.1    Germany

9.3.2    UK

9.3.3    France

9.3.4    Italy

9.3.5    Spain

9.3.6    Rest of Europe

9.4    Asia Pacific

9.4.1    Japan

9.4.2    China

9.4.3    India

9.4.4    Australia

9.4.5    Rest of Asia Pacific

9.5    Latin America

9.5.1    Brazil

9.5.2    Mexico

9.5.3    Rest of Latin America

9.6    Middle East and Africa

9.6.1    South Africa

9.6.2    Saudi Arabia

9.6.3    Rest of Middle East and Africa

Chapter 10   Company Profiles

10.1    Anju Software, Inc.

10.2    Aris Global LLC

10.3    Aurea, Inc.

10.4    Clinevo Technologies

10.5    Cloudbyz

10.6    Egnyte, Inc.

10.7    MasterControl Solutions, Inc.

10.8    Montrium Inc.

10.9    Octalsoft

10.10    Oracle

10.11    SureClinical Inc.

10.12    TransPerfect

10.13    Veeva Systems
 

Authors: Mariam Faizullabhoy, Gauri Wani

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 13
  • Tables & Figures: 246
  • Countries covered: 19
  • Pages: 165
 Download Free Sample